856452-74-9 Usage
Uses
Used in Pharmaceutical Industry:
3-chloro-4-(1H-1,2,4-triazol-1-yl)aniline is used as an intermediate in the synthesis of various drugs. Its unique structure and properties allow for the development of new compounds with potential biological activities, contributing to the discovery of novel therapeutic agents.
Used in Agricultural Industry:
In the agricultural sector, 3-chloro-4-(1H-1,2,4-triazol-1-yl)aniline serves as an intermediate in the production of pesticides. Its chemical properties enable the creation of effective pest control agents, helping to protect crops and ensure food security.
Used in Organic Chemistry:
3-chloro-4-(1H-1,2,4-triazol-1-yl)aniline is an important building block in organic chemistry. Its structure allows for the creation of a wide range of molecules with diverse properties and applications, making it a valuable component in the synthesis of various organic compounds.
Check Digit Verification of cas no
The CAS Registry Mumber 856452-74-9 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 8,5,6,4,5 and 2 respectively; the second part has 2 digits, 7 and 4 respectively.
Calculate Digit Verification of CAS Registry Number 856452-74:
(8*8)+(7*5)+(6*6)+(5*4)+(4*5)+(3*2)+(2*7)+(1*4)=199
199 % 10 = 9
So 856452-74-9 is a valid CAS Registry Number.
InChI:InChI=1/C8H7ClN4/c9-7-3-6(10)1-2-8(7)13-5-11-4-12-13/h1-5H,10H2
856452-74-9Relevant academic research and scientific papers
IMIDAZOQUINOLINES AS LIPID KINASE INHIBITORS
-
Page/Page column 91, (2008/06/13)
The invention relates to novel organic compounds of formula (I) processes for the preparation thereof, the application thereof in a process for the treatment of the human or animal body, the use thereof - alone or in combination with one or more other pharmaceutically active compounds - for the treatment of an inflammatory or obstructive airway disease, such as asthma, disorders commonly occurring in connection with transplantation, or a proliferative disease, such as a tumor disease.
Amide thiadiazole inhibitors of plasminogen activator inhibitor-1
-
Page/Page column 26, (2010/02/12)
Methods of treating disorders associated with elevated levels of PAI-1 are disclosed comprising administering to a patient in need thereof a therapeutically effective amount of at least one compound of formula at least one compound of formula (I), or a ph
